Evaluation of Intralesional Injection of Combined Furosemide and Digoxin Formula in the Treatment of Warts

Articles in Press

Document Type : Original Article

Authors

Department of Dermatology, Andrology and Venereology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt

Abstract

Background: Warts are small, benign growths caused by human papilloma virus (HPV) infection of the skin or mucous membrane. Only few previous studies evaluated a topical formula of combined digoxin and furosemide in the treatment of warts.
Aim of work: to evaluate and verify efficacy of intralesional ionic antiviral injection combined of furosemide and digoxin in treatment of multiple resistant plantar warts.
Patients and Methods: A Double-armed interventional study was performed. A total of 30 patients was recruited from the Outpatient Clinic of Dermatology, Andrology and Venereology Department, Al-Azhar University Hospital.
Results: among the studied cases there were 2 (6.7%) with no response, 5 (16.7%) with partial clearance and 23 (76.7%) with complete clearance, that the mean number of sessions of studied cases was 5.17 (±0.91 SD) with range (4-6), among the studied cases there were 23 (76.7%) with pain and 7 (23.3%) with hemorrhagic bulla and pain with pain score of 6 (±2.36 SD) and 23 (100%) of completely treated cases had no recurrence. Among the mean number of warts after treatment was 0.43 (±0.86 SD) with range (0-3) and the mean size of largest wart after treatment was 0.14 (±0.34 SD) with range (0-1.5). We found a statistically significant relation between Type of clearance and age, disease duration and number of sessions.
Conclusion: Based on our results, Intralesional injection of combined digoxin and furosemide is effective treatment option in multiple plantar warts.

Keywords

Main Subjects

International Journal of Medical Arts

Articles in Press, Accepted Manuscript
Available Online from 16 March 2025

Files

Share

How to cite

Statistics